WALDU
Waldencast Acquisition Corp. [WALDU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
WALDU Stock Summary
In the News
Waldencast Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Redeemable Warrants Commencing May 10, 2021
NEW YORK--(BUSINESS WIRE)--Waldencast Acquisition Corp. (NASDAQ: WALDU) (the “Company”) today announced that, commencing May 10, 2021, holders of the units sold in the Company's initial public offering of 34,500,000 units completed on March 18, 2021, may elect to separately trade the Class A ordinary shares and redeemable warrants included in the units. Those units not separated will continue to trade on The Nasdaq Stock Market LLC (the “Nasdaq”) under the symbol “WALDU,” and the Class A ordina
WALDU Financial details
WALDU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 8.09 | 17.81 | 1.54 | |
| Net income per share | -0.2 | -2.45 | -1.08 | |
| Operating cash flow per share | -0.64 | 0.44 | -0.79 | |
| Free cash flow per share | -0.78 | 0.28 | -0.81 | |
| Cash per share | 0 | 1.6 | 0.08 | |
| Book value per share | 0 | 4.9 | 5.94 | |
| Tangible book value per share | 0 | -10.6 | -1.62 | |
| Share holders equity per share | 0 | 4.9 | 5.94 | |
| Interest debt per share | 0.54 | 16.25 | 1.97 | |
| Market cap | 115.03M | 79.6M | 976.15M | |
| Enterprise value | 115.03M | 185.67M | 1.17B | |
| P/E ratio | -48.54 | -4.07 | -8.37 | |
| Price to sales ratio | 1.22 | 0.56 | 5.88 | |
| POCF ratio | -15.48 | 22.56 | -11.48 | |
| PFCF ratio | -12.59 | 35.5 | -11.15 | |
| P/B Ratio | -10.5K | 2.03 | 1.53 | |
| PTB ratio | -10.5K | 2.03 | 1.53 | |
| EV to sales | 1.22 | 1.3 | 7.02 | |
| Enterprise value over EBITDA | 8.25 | 14.18 | -29.84 | |
| EV to operating cash flow | -15.48 | 52.61 | -13.72 | |
| EV to free cash flow | -12.59 | 82.81 | -13.33 | |
| Earnings yield | -0.02 | -0.25 | -0.12 | |
| Free cash flow yield | -0.08 | 0.03 | -0.09 | |
| Debt to equity | 0 | 3.03 | 0.31 | |
| Debt to assets | 0 | 0.64 | 0.18 | |
| Net debt to EBITDA | 0 | 8.1 | -4.87 | |
| Current ratio | 0.94 | 1.45 | 1.26 | |
| Interest coverage | 0.08 | -0.15 | -5.77 | |
| Income quality | 3.14 | -0.18 | 0.73 | |
| Dividend Yield | 0.02 | 0.03 | 0 | |
| Payout ratio | -0.86 | -0.1 | 0 | |
| Sales general and administrative to revenue | 0 | 0.06 | 0 | |
| Research and developement to revenue | 0.05 | 0.04 | 0.03 | |
| Intangibles to total assets | 0 | 0.67 | 0.89 | |
| Capex to operating cash flow | 0.23 | -0.36 | 0.03 | |
| Capex to revenue | -0.02 | -0.01 | -0.02 | |
| Capex to depreciation | -0.13 | -0.09 | -0.07 | |
| Stock based compensation to revenue | 0 | -0.01 | -0.39 | |
| Graham number | 0.07 | 16.43 | 12.04 | |
| ROIC | -19.82 | -0.02 | -0.08 | |
| Return on tangible assets | -14.21 | -0.32 | -1 | |
| Graham Net | -0.02 | -13.46 | -2.23 | |
| Working capital | -10.95K | 18.23M | 18.54M | |
| Tangible asset value | -10.95K | -84.82M | -173.89M | |
| Net current asset value | -10.95K | -86.31M | -199.13M | |
| Invested capital | 0 | 3.03 | 0.31 | |
| Average receivables | 0 | 9.37M | 19.14M | |
| Average payables | 0 | 6.43M | 18.28M | |
| Average inventory | 0 | 10.81M | 38M | |
| Days sales outstanding | 0 | 48.01 | 42.94 | |
| Days payables outstanding | 2.23 | 84.09 | 68.78 | |
| Days of inventory on hand | 0 | 143.32 | 156.67 | |
| Receivables turnover | 0 | 7.6 | 8.5 | |
| Payables turnover | 163.7 | 4.34 | 5.31 | |
| Inventory turnover | 0 | 2.55 | 2.33 | |
| ROE | 216.42 | -0.5 | -0.18 | |
| Capex per share | -0.15 | -0.16 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0.84 | 0 | 0 | 0 | |
| Net income per share | 0 | -1 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0.43 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0.43 | 0 | 0 | 0 | |
| Cash per share | 0 | 0.09 | 0 | 0 | 0 | |
| Book value per share | 0 | 5.94 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | -4.73 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 5.94 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 1.78 | 0 | 0 | 0 | |
| Market cap | 0 | 976.15M | 0 | 0 | 0 | |
| Enterprise value | 99.73 | 1.17B | 0 | 0 | 0 | |
| P/E ratio | 0 | -2.28 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 10.86 | 0 | 0 | 0 | |
| POCF ratio | 0 | 21.08 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 21.08 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 1.53 | 0 | 0 | 0 | |
| PTB ratio | 0 | 1.53 | 0 | 0 | 0 | |
| EV to sales | 0 | 12.97 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | -37.39 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 25.16 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 25.16 | 0 | 0 | 0 | |
| Earnings yield | 0 | -0.11 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0.05 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0.28 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0.17 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | -6.07 | 0 | 0 | 0 | |
| Current ratio | 0 | 1.26 | 0 | 0 | 0 | |
| Interest coverage | -3.53 | -5.65 | 0 | 0 | 0 | |
| Income quality | -4.96K | -0.43 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.02 | 0.03 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 1.2 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 11.54 | 0 | 0 | 0 | |
| ROIC | 248.81 | -0.06 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0.49 | 0 | 0 | 0 | |
| Graham Net | 0 | -2.21 | 0 | 0 | 0 | |
| Working capital | 99.73 | 18.54M | 0 | 0 | 0 | |
| Tangible asset value | 0 | -508.51M | 0 | 0 | 0 | |
| Net current asset value | 99.73 | -199.13M | 0 | 0 | 0 | |
| Invested capital | 0 | 0.28 | 0 | 0 | 0 | |
| Average receivables | 0 | 9.77M | 9.77M | 0 | 0 | |
| Average payables | 519.66K | 12.12M | 12.12M | 0 | 0 | |
| Average inventory | 0 | 27.19M | 27.19M | 0 | 0 | |
| Days sales outstanding | 0 | 19.58 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 25.32 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 56.78 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 4.6 | 0 | 0 | 0 | |
| Payables turnover | 0 | 3.56 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 1.58 | 0 | 0 | 0 | |
| ROE | 309.39 | -0.17 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
WALDU Frequently Asked Questions
What is Waldencast Acquisition Corp. stock symbol ?
Waldencast Acquisition Corp. is a US stock , located in White plains of Ny and trading under the symbol WALDU
What is Waldencast Acquisition Corp. stock quote today ?
Waldencast Acquisition Corp. stock price is $- today.
Is Waldencast Acquisition Corp. stock public?
Yes, Waldencast Acquisition Corp. is a publicly traded company.
Company Profile
- CEO Mr. Felipe Dutra
- Headquarters White Plains,NY,US
- IPO Date 2021-03-11
-
Website
https://www.waldencast.com/waldencast-acquisition-corp 
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
